{"DataElement":{"publicId":"2685083","version":"2","preferredName":"Non-Hodgkin Lymphoma Transplantation Timepoint Remission Status","preferredDefinition":"Information related to the status of the non-hodgkin's lymphoma at the time of transplant.","longName":"2685081v1.0:2685074v1.1","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2685081","version":"1","preferredName":"Non-Hodgkin Lymphoma Transplantation Timepoint","preferredDefinition":"Distinct from Hodgkin lymphoma both morphologically and biologically, Non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss.  The clinical course varies according to the morphologic type.  NHL is clinically classified as indolent, aggressive, or having a variable clinical course.  NHL can be of B-or T-/NK-cell lineage._The grafting of tissues from one individual to another or place to place within a single individual.__A specific point in the time continuum, including those established relative to an event.","longName":"NHL_TRN_TM","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2676484","version":"1","preferredName":"Non-Hodgkin's Lymphoma","preferredDefinition":"Distinct from Hodgkin's lymphoma both morphologically and biologically, NHL lymphoma is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss.  The clinical course varies according to the morphologic type.  NHL is clinically classified as indolent, aggressive, or having a variable clinical course.  NHL can be of B-or T-/NK-cell lineage. --2003","longName":"C3211","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Hodgkin Lymphoma","conceptCode":"C3211","definition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"393A575A-007A-282D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-03","modifiedBy":"ONEDATA","dateModified":"2007-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2716694","version":"1","preferredName":"Transplantation Timepoint","preferredDefinition":"The grafting of tissues from one individual to another or place to place within a single individual.:A specific point in the time continuum, including those established relative to an event.","longName":"C15342:C68568","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Timepoint","conceptCode":"C68568","definition":"A specific point in the time continuum, including those established relative to an event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41CDDE79-E081-680C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-12-21","modifiedBy":"ONEDATA","dateModified":"2007-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B851CA5-F795-020A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-02","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2685074","version":"1.1","preferredName":"Lymphoma Remission Status","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas._An abatement in intensity or degree (as in the manifestations of a disease)._A condition or state at a particular time.","longName":"2685074v1.1","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Relapse","valueDescription":"RECURRENT DISEASE","ValueMeaning":{"publicId":"2568039","version":"1","preferredName":"RECURRENT DISEASE","longName":"2568039","preferredDefinition":"Recurrent disease","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"PWEST","dateCreated":"2004-01-12","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2092C2C8-7921-1385-E050-BB89AD436D9E","beginDate":"2007-10-02","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"ONEDATA","dateModified":"2015-09-25","deletedIndicator":"No"},{"value":"Complete Response confirmed","valueDescription":"Complete Response, Confirmed","ValueMeaning":{"publicId":"2677065","version":"1","preferredName":"Complete Response, Confirmed","longName":"2677065","preferredDefinition":"Having been established or verified.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39644D6E-B5DD-21D7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User created long name for DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2092C2C8-792B-1385-E050-BB89AD436D9E","beginDate":"2007-10-02","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"ONEDATA","dateModified":"2015-09-25","deletedIndicator":"No"},{"value":"Primary refractory (less than partial response (PR) to initial therapy) / Primary induction failure-resistant (PIF res)","valueDescription":"Primary refractory (less than partial response (PR) to initial therapy) / Primary induction failure-resistant (PIF res)","ValueMeaning":{"publicId":"2685076","version":"1","preferredName":"Primary refractory (less than partial response (PR) to initial therapy) / Primary induction failure-resistant (PIF res)","longName":"2685076","preferredDefinition":"Disease status just prior to the start of the preparative regimen for hematopoietic stem cell transplantation (HSCT): Primary refractory refers to never achieving a complete remission (CR) from any therapy and also not being in partial remission (PR) at the time of the last evaluation prior to HSCT.  PR could have been achieved at some point, but the recipient is no longer in PR.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B83BB14-A4E1-653C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-02","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2092C2C8-7935-1385-E050-BB89AD436D9E","beginDate":"2007-10-02","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"ONEDATA","dateModified":"2015-09-25","deletedIndicator":"No"},{"value":"Never treated","valueDescription":"Never Therapeutic Procedure","ValueMeaning":{"publicId":"2685077","version":"1","preferredName":"Never Therapeutic Procedure","longName":"2685077","preferredDefinition":"Not ever; at no time in the past (or future).: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Never","conceptCode":"C70543","definition":"Not ever; at no time in the past (or future).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B83BB14-A509-653C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-02","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2092C2C8-793F-1385-E050-BB89AD436D9E","beginDate":"2007-10-02","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"ONEDATA","dateModified":"2015-09-25","deletedIndicator":"No"},{"value":"Partial response (PR)","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2559721","version":"1","preferredName":"Partial Response","longName":"2559721","preferredDefinition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response","conceptCode":"C18212","definition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B656-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2092C2C8-7949-1385-E050-BB89AD436D9E","beginDate":"2008-01-22","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"ONEDATA","dateModified":"2015-09-25","deletedIndicator":"No"},{"value":"CR unconfirmed (CRU) (complete response with persistent scan abnormalities of unknown signifcance)","valueDescription":"Not Confirmed CR","ValueMeaning":{"publicId":"2677064","version":"1","preferredName":"Not Confirmed CR","longName":"2677064","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Confirmed; having been established or verified.: The disappearance of all signs of cancer in response to treatment.  This does not always mean the cancer has been cured.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39644D6E-B5B5-21D7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2092C2C8-7953-1385-E050-BB89AD436D9E","beginDate":"2008-06-16","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"ONEDATA","dateModified":"2015-09-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2716707","version":"1","preferredName":"Lymphoma Remission Status","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003:An abatement in intensity or degree (as in the manifestations of a disease).:A condition or state at a particular time.","longName":"C3208:C18246:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Remission","conceptCode":"C18246","definition":"An abatement in intensity or degree (as in the manifestations of a disease).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41CF66AE-8BB3-0D41-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-12-21","modifiedBy":"ONEDATA","dateModified":"2007-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2092C2C8-790A-1385-E050-BB89AD436D9E","latestVersionIndicator":"Yes","beginDate":"2015-09-25","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"KUMMEROA","dateModified":"2021-02-23","changeDescription":". 2021-2-23 ak Ok to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedDiagnosis:diseaseStatusCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"pre_ted_nhl_status_hsct","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the status of the no","type":"Preferred Question Text","description":"What was the status of the non-hodgkin's lymphoma at the time of transplantation?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2685083","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.diseaseStatusCode WHERE PerformedDiagnosis.value = \"non-hodgkin\"s lymphoma\" AND PerformedDiagnosis > PerformedObservation.dateRange IS LESS THAN OR EQUAL TO PerformedSubstanceAdministration.dateRange AND PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Administer Hematopoietic Cell Product{ Transplantation}\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2092EF2C-755F-885E-E050-BB89AD43277B","latestVersionIndicator":"Yes","beginDate":"2015-09-25","endDate":null,"createdBy":"NYCHM","dateCreated":"2015-09-25","modifiedBy":"KUMMEROA","dateModified":"2021-02-23","changeDescription":".-2021-2-23 ak OK to release per WZ. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}